Hydroxylamine solution

• Catalog No.: 467804
• CAS Number: 7803-49-8
• M. F.: H3NO
• M. W.: 33.02992
• Purity: 99.999%

SYNONYMS

• Title: 羟胺 溶液
• IUPAC name: hydroxylamine
• IUPAC Traditional name: hydroxylamine
• Synonyms: HDA

DATABASE IDS

• CAS Number: 7803-49-8
• MDL Number: MFCD00044522
• PubChem SID: 24870439
• EC Number: 232-259-2

PROPERTIES

• Concentration: 50 wt. % in H2O
• Linear Formula: NH2OH
• Purity: 99.999%
• Boiling Point: 107 °C
• Density: 1.078 g/mL at 25 °C
• GHS Signal Word: Danger
• GHS Hazard statements: H290-H302-H312-H315-H317-H318-H335-H351-H373-H400
• European Hazard Symbols: Harmful (Xn)
• European Hazard Symbols: Nature polluting (N)
• Personal Protective Equipment: Eyeshields, Faceshields, full-face respirator (US), Gloves, multi-purpose combination respirator cartridge (US), type ABEK (EN14387) respirator filter
• GHS Precautionary statements: P261-P273-P280-P305 + P351 + P338
• RID/ADR: UN 3082 9/PG 3
• Risk Statements: 5-21/22-37/38-40-41-43-48/22-50
• RTECS: NC2975000
• Safety Statements: 26-36/37/39-46-61
• Hazard Class: 9
• UN Number: 3082
• Packing Group: 3
• German water hazard class: 3

DETAILS

Description (English)

Packaging
10, 50 mL in poly bottle
Application
Reactant for preparation of:
• Prodrug for cardiovascular agent Nω-hydroxy-L-arginine (NOHA, nitric oxide precursor)1
• Hydroxyaminoguanidines as anti-cancer agents2
• Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced phosphoenolpyruvate caboxykinase (PEPCK) transactivation3
• Carboxamide derivatives of ofloxacin with improved antimicrobial properties4
• Analogues of coumarin based TNF-α converting enzyme (TACE) inhibitors5
• HIV integrase inhibitors6

Description (简体中文)

包装
10, 50 mL in poly bottle
Application
Reactant for preparation of:
• Prodrug for cardiovascular agent Nω-hydroxy-L-arginine (NOHA, nitric oxide precursor)1
• Hydroxyaminoguanidines as anti-cancer agents2
• Nonsteroidal 2,3-dihydroquinoline glucocorticoid receptor agonists with reduced phosphoenolpyruvate caboxykinase (PEPCK) transactivation3
• Carboxamide derivatives of ofloxacin with improved antimicrobial properties4
• Analogues of coumarin based TNF-α converting enzyme (TACE) inhibitors5
• HIV integrase inhibitors6